KR-27452 is a selective and orally active PI4KIIIbeta inhibitor with an IC50 of 0.026 µM, while showing no activity against PI4KIIIalpha (IC50 >10 µM) . KR-27452 specifically binds to and inhibits PI4KIIIbeta, leading to reduced viral replication in cells. KR-27452 exhibits strong antiviral activity against human rhinovirus (RVs) and Coxsackievirus (COXs). KR-27452 can be used for the research of infection[1].
Molekulargewicht:
453.55
Formel:
C24H27N3O4S
Target-Kategorie:
Enterovirus,PI4K
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
